NORTH READING, Mass. and ARLINGTON, Va., Feb. 6, 2018 /PRNewswire/ -- TraceLink Inc.,and the Healthcare Distribution Alliance (HDA) today announced that TraceLink will dismiss litigation claims that it asserted against HDA, which stated that HDA participated in conspiracies to unreasonably restrain trade and to monopolize. TraceLink
As part of the agreement, HDA reaffirms its stance that all members of the healthcare supply chain should have the freedom to use any, or contribute data to any, traceability product or database that they choose, as long as the solution of choice complies with relevant industry standards and guidelines. HDA also reaffirms that it will not mandate use of, or data contribution to, the HDA's data repository known as Origin for any of its members or their supply chain partners.
About TraceLinkTraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 177 in 2017), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
About the Healthcare Distribution Alliance The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors the vital link between the nation's pharmaceutical manufacturers and more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA's non-profit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.
View original content:http://www.prnewswire.com/news-releases/tracelink-dismisses-litigation-claims-against-healthcare-distribution-alliance-hda-300594568.html
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All